ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced today that it has received financing approvals from Bpifrance and Société Générale for a total of €10 million in the form of State-Guaranteed Loans (Prêts Garantis par l’Etat, or PGE in France) in the context of the COVID-19 pandemic.

Menu